IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Tumor Diagnostik und Therapie- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

0.02

h-Index

 6

Rank

 24907

SJR

 0.106

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Tumor Diagnostik und Therapie
Abbreviation Tumor Diagn. Ther.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q4)
h-index 6
Overall Rank/Ranking 24907
SCImago Journal Rank (SJR) 0.106
Impact Score 0.02
Publisher Georg Thieme Verlag
Country Germany
ISSN 0722219X, 14391279




About Tumor Diagnostik und Therapie


Tumor Diagnostik und Therapie is a journal covering the technologies/fields/categories related to Oncology (Q4). It is published by Georg Thieme Verlag. The overall rank of Tumor Diagnostik und Therapie is 24907. According to SCImago Journal Rank (SJR), this journal is ranked 0.106. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 6. The best quartile for this journal is Q4.

The ISSN of Tumor Diagnostik und Therapie journal is 0722219X, 14391279. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Tumor Diagnostik und Therapie is cited by a total of 10 articles during the last 3 years (Preceding 2021).


Tumor Diagnostik und Therapie Impact Score 2021-2022


The impact score (IS) 2021 of Tumor Diagnostik und Therapie is 0.02, which is computed in 2022 as per its definition. Tumor Diagnostik und Therapie IS is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Tumor Diagnostik und Therapie Impact Score 2022 Prediction


IS 2021 of Tumor Diagnostik und Therapie is 0.02. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Tumor Diagnostik und Therapie. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.02
2020 0.02
2019 0.00
2018 0.00
2017 0.01
2016 0.03
2015 0.00
2014 0.00

Tumor Diagnostik und Therapie h-index


  Table Setting

Tumor Diagnostik und Therapie has an h-index of 6. It means 6 articles of this journal have more than 6 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Tumor Diagnostik und Therapie ISSN


The ISSN of Tumor Diagnostik und Therapie is 0722219X, 14391279. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Tumor Diagnostik und Therapie Rank and SCImago Journal Rank (SJR)


The overall rank of Tumor Diagnostik und Therapie is 24907. According to SCImago Journal Rank (SJR), this journal is ranked 0.106. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Tumor Diagnostik und Therapie Publisher


Table Setting

Tumor Diagnostik und Therapie is published by Georg Thieme Verlag. It's publishing house is located in Germany. Coverage history of this journal is as following: 1983-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Tumor Diagnostik und Therapie is Tumor Diagn. Ther.. This abbreviation ('Tumor Diagn. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Tumor Diagnostik und Therapie


If your research field is/are related to Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Bibliotecas, Anales de Investigacion journal 21122 Biblioteca Nacional de Cuba Jose Marti 3 0.32
Concussion journal 10978 Future Medicine Ltd. 9 1.71
Journal of Microencapsulation journal 8743 Informa Healthcare 81 3.35
Dilbilim Arastirmalari Dergisi journal 24010 Bogazici University Press 1 0.08
International Planning Studies journal 7112 Routledge 44 2.46
Chronic Respiratory Disease journal 6564 SAGE Publications Ltd 43 2.37
International Information and Library Review journal 14789 Taylor and Francis Ltd. 27 1.45
Review of Religious Research journal 11032 Religious Research Association 42 0.96
International Journal of Wireless Information Networks journal 9995 Springer New York 31 2.33
Empirical Economics journal 9353 Physica-Verlag 60 1.62

Check complete list




Year wise Impact Score (IS) of Tumor Diagnostik und Therapie

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.02
2020 0.02
2019 0.00
2018 0.00
2017 0.01
2016 0.03
2015 0.00
2014 0.00



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All